{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:12:36Z","timestamp":1790835156441,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"am","delay-in-days":296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","award":["SAF2015-68346-P"],"award-info":[{"award-number":["SAF2015-68346-P"]}],"id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017SGR717"],"award-info":[{"award-number":["2017SGR717"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.neuropharm.2020.108309","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:47:18Z","timestamp":1600429638000},"page":"108309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Serotonin2B receptor blockade in the rat dorsal raphe nucleus suppresses cocaine-induced hyperlocomotion through an opposite control of mesocortical and mesoaccumbens dopamine pathways"],"prefix":"10.1016","volume":"180","author":[{"given":"Adeline","family":"Cathala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Devroye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9l\u00e9a","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Revest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Spampinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108309_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.108309_bib2","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/0006-2952(79)90549-5","article-title":"GABA agonists and antagonists","volume":"28","author":"Andrews","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108309_bib3","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1471-4159.2010.06848.x","article-title":"The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity","volume":"114","author":"Auclair","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108309_bib4","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1021\/jm960062t","article-title":"Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus","volume":"39","author":"Audia","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108309_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cne.901790311","article-title":"An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat","volume":"179","author":"Azmitia","year":"1978","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108309_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","article-title":"Akt\/GSK3 signaling in the action of psychotropic drugs","volume":"49","author":"Beaulieu","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2020.108309_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2020.108309_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.euroneuro.2009.01.014","article-title":"Effects of the dopamine stabilizer, OSU-6162, on brain stimulation reward and on quinpirole-induced changes in reward and locomotion","volume":"19","author":"Benaliouad","year":"2009","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108309_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0079-6123(08)00914-X","article-title":"Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression","volume":"172","author":"Berg","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108309_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/ejn.12068","article-title":"Lesion of medial prefrontal dopamine terminals abolishes habituation of accumbens shell dopamine responsiveness to taste stimuli","volume":"37","author":"Bimpisidis","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0893-133X(02)00311-1","article-title":"SR46349-B, a 5-HT(2A\/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens","volume":"27","author":"Bonaccorso","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0702632","article-title":"RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist","volume":"127","author":"Bonhaus","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108309_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0306-4522(99)00287-0","article-title":"Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion","volume":"94","author":"Broersen","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108309_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108309_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2018.09.015","article-title":"Serotonin2B receptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons","volume":"311","author":"Cathala","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108309_bib17","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1523\/JNEUROSCI.21-24-09917.2001","article-title":"Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate Receptors","volume":"21","author":"Celada","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/cn300072u","article-title":"Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction","volume":"4","author":"Cunningham","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00210-001-0505-y","article-title":"Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols","volume":"365","author":"Cussac","year":"2002","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108309_bib20","first-page":"58","article-title":"Role of beta-arrestin 2 downstream of dopamine receptors in the basal ganglia","volume":"5","author":"Del'Guidice","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuropharm.2020.108309_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuropharm.2015.06.012","article-title":"Central serotonin(2B) receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow","volume":"97","author":"Devroye","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuropharm.2016.05.024","article-title":"Differential control of dopamine ascending pathways by serotonin2B receptor antagonists: new opportunities for the treatment of schizophrenia","volume":"109","author":"Devroye","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2017.07.014","article-title":"The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: rationale and current status of research","volume":"181","author":"Devroye","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.108309_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00221-013-3593-2","article-title":"Serotonin2C receptors and drug addiction: focus on cocaine","volume":"230","author":"Devroye","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108309_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuropharm.2017.04.001","article-title":"Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin2B receptor blockade: involvement of medial prefrontal cortex serotonin1A receptors","volume":"119","author":"Devroye","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib26","doi-asserted-by":"crossref","first-page":"10372","DOI":"10.1523\/JNEUROSCI.1354-17.2017","article-title":"Serotonin 2B receptors in mesoaccumbens dopamine pathway regulate cocaine responses","volume":"37","author":"Doly","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1469-185X.1992.tb01191.x","article-title":"The functional role of mesotelencephalic dopamine systems","volume":"67","author":"Dunnett","year":"1992","journal-title":"Biol. Rev. Camb. Phil. Soc."},{"key":"10.1016\/j.neuropharm.2020.108309_bib28","first-page":"576","article-title":"Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding","volume":"27","author":"Fletcher","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00213-006-0453-9","article-title":"The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists","volume":"187","author":"Fletcher","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/jpet.102.045716","article-title":"Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex","volume":"306","author":"Filip","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108309_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainres.2012.03.035","article-title":"Pharmacological and genetic interventions in serotonin (5-HT)(2C) receptors to alter drug abuse and dependence processes","volume":"1476","author":"Filip","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108309_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.20738","article-title":"Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers","volume":"492","author":"Gabbott","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108309_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.beproc.2010.12.013","article-title":"Locomotor activity in a novel environment predicts both responding for a visual stimulus and self-administration of a low dose of methamphetamine in rats","volume":"86","author":"Gancarz","year":"2011","journal-title":"Behav. Process."},{"key":"10.1016\/j.neuropharm.2020.108309_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D","article-title":"Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat","volume":"36","author":"Gobert","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2020.108309_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108309_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/pr.114.009514","article-title":"Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder","volume":"67","author":"Howell","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108309_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0006-3223(91)90144-B","article-title":"Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus","volume":"29","author":"Jaskiw","year":"1991","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108309_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","article-title":"SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1747-0285.2010.01011.x","article-title":"Structural combination of established 5-HT(2A) receptor ligands: new aspects of the binding mode","volume":"76","author":"Kramer","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.neuropharm.2020.108309_bib40","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/jnc.12222","article-title":"Decrease of GSK3\u03b2 phosphorylation in the rat nucleus accumbens core enhances cocaine-induced hyper-locomotor activity","volume":"125","author":"Kim","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108309_bib41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0306-4522(95)00246-F","article-title":"Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: an in vivo neurochemical assessment in the rhesus monkey","volume":"69","author":"Kolachana","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108309_bib42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0306-4522(00)00013-0","article-title":"The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion","volume":"97","author":"Lacroix","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108309_bib43","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.neuron.2008.01.022","article-title":"Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system","volume":"57","author":"Lammel","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108309_bib44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuropharm.2008.10.005","article-title":"Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens","volume":"56","author":"Leggio","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00213-005-0170-9","article-title":"ACP-103, a 5-HT2A\/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens","volume":"183","author":"Li","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0306-4522(89)90331-X","article-title":"Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study","volume":"29","author":"Louilot","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108309_bib47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1471-4159.2000.740693.x","article-title":"Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum","volume":"74","author":"Lucas","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108309_bib48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jneumeth.2011.04.001","article-title":"Western blot detection of brain phosphoproteins after performing Laser Microdissection and Pressure Catapulting (LMPC)","volume":"198","author":"Maitre","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2020.108309_bib49","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuropharm.2009.03.006","article-title":"Cocaine-induced hyperactivity and sensitization are dependent on GSK3","volume":"56","author":"Miller","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.npp.1300329","article-title":"In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum","volume":"29","author":"Navailles","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib51","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/0024-3205(83)90674-4","volume":"33","author":"Nielsen","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib52","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.neuropharm.2020.108309_bib53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0024-3205(88)90425-0","article-title":"Cocaine and central monoaminergic neurotransmission: a review of electrophysiological studies and comparison to amphetamine and antidepressants","volume":"42","author":"Pitts","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0893-133X(01)00333-5","article-title":"5-HT2A and 5-HT2C\/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum","volume":"26","author":"Porras","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1471-4159.2002.00947.x","article-title":"Stimulation of 5-hydroxytryptamine (5-HT(2C) ) receptors in the ventrotegmental Area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex","volume":"82","author":"Pozzi","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108309_bib56","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-007-0791-2","article-title":"Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats","volume":"193","author":"Pum","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108309_bib57","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/mp.2010.40","article-title":"The enhancement of stress-related memory by glucocorticoids depends on synapsin-Ia\/Ib","volume":"1125","author":"Revest","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108309_bib58","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jnc.12206","article-title":"Transient and rapid activation of Akt\/GSK-3\u03b2 and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens","volume":"125","author":"Salles","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108309_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnana.2017.00087","article-title":"Laminar and cellular distribution of monoamine receptors in rat medial prefrontal cortex","volume":"11","author":"Santana","year":"2017","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuropharm.2020.108309_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1300.066","article-title":"Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions","volume":"1003","author":"Sesack","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/jpet.118.251199","article-title":"The 5-HT(2A) receptor (5-HT(2A)R) regulates impulsive action and cocaine cue reactivity in male sprague-dawley rats","volume":"368","author":"Sholler","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108309_bib62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(92)90819-P","article-title":"5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine","volume":"223","author":"Schmidt","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108309_bib63","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1460-9568.1997.tb01375.x","article-title":"Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine","volume":"9","author":"Tanda","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib64","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1124\/jpet.102.038133","article-title":"GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system","volume":"303","author":"Tao","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108309_bib65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0301-0082(00)00033-2","article-title":"Pharmacology and behavioral pharmacology of the mesocortical dopamine system","volume":"63","author":"Tzschentke","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.108309_bib66","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1460-9568.1991.tb00036.x","article-title":"Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: a role for the cortical D-1 dopamine receptor","volume":"3","author":"Vezina","year":"1991","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tins.2009.06.004","article-title":"Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction","volume":"32","author":"Wise","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108309_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2019.108543","article-title":"Alpha technology: a powerful tool to detect mouse brain intracellular signaling events","volume":"332","author":"Zanese","year":"2020","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2020.108309_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/syn.21922","article-title":"GSK-3\u03b2 inhibitors reverse cocaine-induced synaptic transmission dysfunction in the nucleus accumbens","volume":"70","author":"Zhao","year":"2016","journal-title":"Synapse"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:56:26Z","timestamp":1777449386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820303774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":69,"alternative-id":["S0028390820303774"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108309","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonin2B receptor blockade in the rat dorsal raphe nucleus suppresses cocaine-induced hyperlocomotion through an opposite control of mesocortical and mesoaccumbens dopamine pathways","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108309"}}